CIPLA
Back to Balance Sheet
|
CIPLA Last 5 Year Long Term Provisions History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Long Term Provisions | ₹149 Cr | ₹129 Cr | ₹102 Cr | ₹100 Cr | ₹116 Cr |
What is the latest Long Term Provisions ratio of CIPLA ?
Year | Long Term Provisions |
---|---|
Mar2025 | ₹149 Cr |
Mar2024 | ₹129 Cr |
Mar2023 | ₹102 Cr |
Mar2022 | ₹100 Cr |
Mar2021 | ₹116 Cr |
How is Long Term Provisions of CIPLA Trending?
Years | Long Term Provisions | % Change | |
---|---|---|---|
Mar2025 | ₹149 Cr | 15.03 | |
Mar2024 | ₹129 Cr | 26.53 | |
Mar2023 | ₹102 Cr | 1.94 | |
Mar2022 | ₹100 Cr | -13.73 | |
Mar2021 | ₹116 Cr | - |
Compare Long Term Provisions of peers of CIPLA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
CIPLA | ₹121,195.4 Cr | -1.7% | 2.3% | -5.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹399,249.0 Cr | -1.3% | -3.3% | 8.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹174,940.0 Cr | -1.5% | 0.8% | 42.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹110,618.0 Cr | -1.6% | 8.4% | 10.6% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹107,250.0 Cr | -3.3% | -1.4% | 9.8% | Stock Analytics | |
MANKIND PHARMA | ₹94,475.7 Cr | -3.3% | -6.1% | 3.4% | Stock Analytics |
CIPLA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
CIPLA | -1.7% |
2.3% |
-5.8% |
SENSEX | 1.6% |
1% |
7% |
You may also like the below Video Courses